Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients.

@article{Bal2004RadioiodineDF,
  title={Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients.},
  author={Chandrasekhar S Bal and Ajay Kumar and Gauri Shankar Pant},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2004},
  volume={89 4},
  pages={
          1666-73
        }
}
Remnant ablation can be achieved by either administering an empiric fixed dose or using dosimetry-guided techniques. Because of the technical and logistic difficulties, most centers have adapted the fixed-dose or standard-dose technique for remnant ablation using (131)I. In the late 1970s, low-dose (131)I remnant ablation was introduced, and subsequently many centers confirmed the effectiveness of such therapy. However, the optimal dose (administered activity) of (131)I for remnant ablation is… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 71 CITATIONS, ESTIMATED 42% COVERAGE

Practical Management of Thyroid Cancer

  • Springer International Publishing
  • 2018
VIEW 10 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Chinese Data of Efficacy of Low- and High-Dose Iodine-131 for the Ablation of Thyroid Remnant.

  • Thyroid : official journal of the American Thyroid Association
  • 2016
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

The AEC/NRC 30 mCi rule: regulatory origins and clinical consequences for 131I remnant ablative doses.

  • Thyroid : official journal of the American Thyroid Association
  • 2014
VIEW 5 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2004
2018

CITATION STATISTICS

  • 7 Highly Influenced Citations